机构:[1]Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.[2]Cancer Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, Guangdong, China.[3]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.[4]The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.[5]Department of Oncology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.[6]Brain Hospital of Hunan Province, Changsha, Hunan, China.[7]Department of Gastroenterology, Hunan People's Hospital, Changsha, Hunan, China.
第一作者机构:[1]Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.[2]Cancer Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, Guangdong, China.[3]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.
共同第一作者:
通讯作者:
通讯机构:[1]Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.[2]Cancer Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, Guangdong, China.[3]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.[*1]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China[*2]Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China
推荐引用方式(GB/T 7714):
Lin Xian,Zuo Shi,Luo Rongcheng,et al.HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.[J].Theranostics.2019,9(25):7583-7598.doi:10.7150/thno.37717.
APA:
Lin Xian,Zuo Shi,Luo Rongcheng,Li Yonghao,Yu Guifang...&Liu Zhen.(2019).HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma..Theranostics,9,(25)
MLA:
Lin Xian,et al."HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.".Theranostics 9..25(2019):7583-7598